Sage — Heart Failure

Sage — Cardiomyopathy and Heart Failure

Disclaimer

This essay presents a metabolic hypothesis intended for intellectual exploration. It is not medical advice, diagnosis, or a treatment protocol. Mechanisms discussed are interpretive except where a specific experimental result is cited. Individual circumstances vary; any interventions should be undertaken only under appropriate medical supervision.

We are born with perfect biology. That is the first and most radical claim of the metabolic philosophy of medicine. Perfect for intermittent fuel availability, natural circadian entrainment, and the obligatory movement-strength hormesis that defined hominin life. What we label disease is, in the overwhelming majority of chronic cases, not a random error or a software bug in the genome. It is the predictable downstream consequence of a biology operating in chronic compensatory mode because its upstream ATP-generating capacity has been chronically compromised by mismatch. Acute compensation is life-saving. Chronic compensation becomes the pathology we name and attempt to suppress.

Two related bioenergetic responses illustrate the distinction. The Crabtree effect is the reversible suppression of oxidative phosphorylation that occurs in some cells when glucose is abundant; substrate-level phosphorylation rises temporarily while mitochondria remain competent. The Warburg effect is the persistent reliance on aerobic glycolysis and reduced metabolic flexibility that appears when mitochondrial ATP-generating headroom has been eroded and the compensatory program locks in. Acute Crabtree-like shifts can still reverse when load falls or oxidative capacity is restored. On this hypothesis, chronic Warburg-like shifts become architecture: fragmented mitochondria, suppressed fatty-acid oxidation, lipotoxicity, fibrosis, and the named syndromes of the heart.

The heart is the specialized organ of distribution for the dual-delivery architecture that powers oxidative phosphorylation. The gastrointestinal tract delivers oxidizable fuel substrates into the circulation; the lungs deliver the magnetic acceptor—molecular oxygen—that completes the redox circuit and permits oxidative phosphorylation. The heart then distributes the oxygenated, fuel-laden blood under continuous mechanical and electrical load, while the right ventricle and pulmonary vasculature form the immediate coupled partner of the oxidizer-delivery axis. Cardiac health is therefore inseparable from gastrointestinal fuel quality and timing, pulmonary oxygen tension and right-heart resilience, systemic iron homeostasis, and the holobiont microbiome that educates both mucosal surfaces and systemic inflammatory set-points. Named heart diseases are tissue-specific expressions of the same upstream constraint seen systemically: insufficient oxidative ATP capacity relative to load, forcing compensatory hypertrophy, dilation, fibrosis, electrical instability, or neoplastic selection in the vascular wall.

Core Architecture: Sensing, Delivery, and Modulation

The heart is not a passive pump. Cardiomyocytes contain the highest mitochondrial volume density of any cell type, approaching 30 percent of cellular volume, organized in a lattice that surrounds the contractile apparatus and the sarcoplasmic reticulum. This architecture supports continuous excitation-contraction coupling whose ATP demand is among the highest in the organism. Under ancestral conditions the preferred substrate is long-chain fatty acids delivered by β-oxidation, with metabolic flexibility to glucose, lactate, and ketone bodies according to intermittent availability. Heart-type isoforms of cytochrome c oxidase nuclear-encoded subunits (including VIa-H, VIIa-H and related) fine-tune basal activity, proton stoichiometry, and allosteric responsiveness to the high and fluctuating energetic demand of myocardium; their developmental switch from liver-type isoforms after birth is part of the maturation that equips the organ for lifelong work. Calcium handling is inseparably coupled to energetics: mitochondrial calcium uptake stimulates the TCA-cycle dehydrogenases, matching reducing-equivalent supply to demand during each beat, while the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA) and the sarcolemmal Na⁺/K⁺-ATPase are among the largest continuous consumers of ATP.

Iron and redox modulators are active participants in this circuit. Iron is the cofactor of hemoglobin, of heme-containing cytochromes, and of Fe-S clusters in complexes I, II and III. Absolute or functional iron deficiency impairs electron transport and contractility even in the absence of anemia; conversely, labile iron catalyzes Fenton chemistry and ferroptosis. Serotonin, produced by pulmonary neuroendocrine cells and taken up by cardiac endothelium and myocytes, modulates vascular tone, hypertrophy signaling, and arrhythmogenic remodeling. The gut-heart axis further couples the fuel-delivery and oxidizer-delivery systems: short-chain fatty acids, tryptophan metabolites, secondary bile acids, trimethylamine N-oxide, and microbial ligands shape endothelial nitric-oxide bioavailability, macrophage metabolism, and systemic inflammatory tone, while cardiac output and right-heart pressure reciprocally influence splanchnic perfusion and barrier integrity.

Shared Pathways Under Fuel and Oxidizer Constraint

Across chronic cardiac disease, mitochondrial dysfunction—impaired electron-transport-chain flux (especially complex I), excess reactive oxygen species, aberrant fission-fusion dynamics, and defective mitophagy—is a unifying feature in cardiomyocytes, endothelium, pericytes, and resident immune cells. In myocardium, chronic substrate overload or toxic exposures reduce oxidative phosphorylation or force a maladaptive shift toward glycolysis. In the vascular wall, redox imbalance and mtDNA damage drive endothelial dysfunction and smooth-muscle proliferation. These are not independent lesions. They are the local expression of insufficient ATP-generating headroom, forcing reliance on compensatory hypertrophy (via mTOR and related pathways), inflammatory recruitment, fibrotic lock-in, or arrhythmogenic ion-channel remodeling. Systemic metabolic syndrome, circadian disruption, and absent contractile hormesis lower the threshold at which pressure overload, intermittent hypoxia, or lipid excess lock these compensations into place.

Metabolic Atherosclerosis: Vascular Remodeling under Constraint

Atherosclerosis is conventionally framed as a lipid-storage disease. Through the metabolic lens it is an energy-constrained state of the arterial wall. Endothelial cells and vascular smooth-muscle cells exhibit reduced oxidative capacity, excess ROS, and a glycolytic shift analogous to the Warburg phenotype seen in other tissues under chronic stress. Oxidized lipoproteins and iron-catalyzed peroxidation amplify mitochondrial damage; mtDNA fragments and ROS further activate innate immune sensors, recruiting macrophages that themselves undergo metabolic reprogramming. Foam-cell formation is, in part, a failed attempt to sequester and oxidize lipid under conditions of impaired mitochondrial clearance. Gut-derived trimethylamine N-oxide and reduced short-chain fatty acid production lower the threshold for endothelial dysfunction and plaque progression. The named syndrome is the chronic expression of a vessel wall whose ATP-generating headroom, iron-redox balance, and gut-derived regulatory signals have been eroded by mismatch. Ischemic cardiomyopathy is the downstream consequence once coronary flow can no longer meet the already compromised myocardial demand.

Cardiomyopathy and Heart Failure: Accelerated Compensatory Remodeling

Heart failure is the histological and functional record of chronic energy starvation under sustained load. The failing myocardium exhibits reduced fatty-acid oxidation capacity, a compensatory (yet ultimately insufficient) increase in glucose uptake and glycolysis, accumulation of incompletely oxidized lipid intermediates, and a decline in phosphocreatine-to-ATP ratio. This shift, once viewed as adaptive, is energetically inefficient and generates excess ROS; it does not restore ATP headroom. Early in pressure or substrate overload the rise in glycolysis may be a Crabtree-like adjustment while fatty-acid oxidation remains dominant (Allard et al. 1994; Taegtmeyer et al. 2010). When mitophagy and biogenesis fail, the shift may lock into a Warburg-like state of suppressed fatty-acid oxidation, lipid accumulation, and fibrotic signaling. On this hypothesis, this is the cardiac Warburg transition. Dilated cardiomyopathy reflects failed maintenance of sarcomeric and extracellular architecture once energy-costly processes of protein turnover, calcium cycling, and debris clearance can no longer be sustained. Hypertrophic remodeling is an attempt to increase force generation under pressure or volume load, yet the same mitochondrial attrition that necessitated the hypertrophy limits its utility and promotes fibrosis. Heart failure with reduced ejection fraction is dominated by excitation-contraction uncoupling and mechano-energetic mismatch; heart failure with preserved ejection fraction is dominated by afterload-driven energy demand that outstrips mitochondrial supply, often in the setting of systemic metabolic syndrome. Iron deficiency—whether systemic or cardiomyocyte-specific—further impairs Fe-S cluster biogenesis and electron transport, independent of anemia, and is present in roughly half of patients. Progressive loss of contractile reserve is the organ-level summation of progressive mitochondrial attrition amplified by unique continuous load and fluctuating oxygen and substrate delivery.

Reference: Allard MF, Schönekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. American Journal of Physiology 1994;267(2 Pt 2):H742–H750. doi:10.1152/ajpheart.1994.267.2.H742

Reference: Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Annals of the New York Academy of Sciences 2010;1188:191–198. doi:10.1111/j.1749-6632.2009.05100.x

Pulmonary Interactions: The Right Heart as Coupled Oxidizer Partner

The right ventricle and pulmonary vasculature form the immediate interface with the oxidizing-magnet delivery system. Pulmonary arterial hypertension exhibits a Warburg-like glycolytic shift in pulmonary arterial smooth-muscle cells and in right-ventricular myocytes, driven by mitochondrial hyperpolarization, excess ROS, and impaired pyruvate dehydrogenase activity. The same high-activity lung COX isoform that enables hypoxic vasoconstriction can, under chronic toxic or hypoxic load, contribute to inflammatory and apoptotic cascades that elevate right-ventricular afterload. Intermittent hypoxia of obstructive sleep apnea imposes repeated ischemia-reperfusion injury on both pulmonary endothelium and right-ventricular mitochondria, promoting permeability transition, endothelial dysfunction, and progressive right-heart strain. Cor pulmonale is therefore not an independent entity; it is the cardiac expression of the same oxidizer-delivery failure described in the pulmonary hypothesis, amplified by the continuous mechanical work of the right ventricle. Restoring systemic oxidative capacity simultaneously improves right-heart resilience and reduces the pulmonary vascular load that feeds it.

Gastrointestinal Interactions: The Gut-Heart Axis

The gastrointestinal tract is the upstream source of oxidizable substrate and of the microbial metabolites that calibrate cardiac and vascular set-points. Dysbiosis reduces short-chain fatty acid production (which supports endothelial nitric-oxide synthase and anti-inflammatory macrophage polarization) while elevating trimethylamine N-oxide, phenylacetylglutamine, and lipopolysaccharide translocation across a compromised barrier. These signals promote endothelial dysfunction, platelet activation, and systemic inflammation that further impair myocardial mitochondrial quality. Substrate quality and timing determine the Randle-cycle set-point: chronic fermentable carbohydrate load and excess long-chain fatty acids of poor quality drive incomplete oxidation, lipid accumulation, and PDH inhibition, locking the myocardium into the inefficient glycolytic phenotype of heart failure. Conversely, ancestral fuel patterns—animal fats and proteins, microbially accessible carbohydrates, intermittent ketosis—restore metabolic flexibility, improve the NAD⁺/NADH ratio, and reduce the inflammatory tone that amplifies every cardiac compensation. The gut-heart dialogue is bidirectional: low cardiac output itself impairs splanchnic perfusion and barrier integrity, creating a self-reinforcing loop.

Deep Dive into Cardiac Metabolic Pathways

The adult heart derives 60–90 percent of its ATP from fatty-acid β-oxidation under resting conditions, with the balance from glucose, lactate, and ketones. Entry of long-chain fatty acyl-CoA into mitochondria is gated by carnitine palmitoyltransferase-1, itself inhibited by malonyl-CoA generated by acetyl-CoA carboxylase. Once inside, successive cycles of β-oxidation yield acetyl-CoA that enters the TCA cycle, generating NADH and FADH₂ for the electron-transport chain. The Randle cycle describes the reciprocal inhibition whereby elevated acetyl-CoA, NADH, and citrate from fatty-acid oxidation suppress pyruvate dehydrogenase and phosphofructokinase, thereby sparing glucose. In the failing heart this circuit is disrupted: transcriptional downregulation of PPARα and PGC-1α reduces fatty-acid oxidation enzymes, incomplete β-oxidation generates toxic intermediates, and the compensatory rise in glycolysis cannot restore ATP yield while increasing ROS. Ketone bodies (β-hydroxybutyrate) bypass several of these bottlenecks, improve the NAD⁺/NADH ratio, and are efficiently oxidized even when fatty-acid pathways are impaired; their elevation under ancestral fasting or carbohydrate restriction therefore constitutes a physiological rescue substrate. Mitochondrial calcium uptake continues to stimulate isocitrate and α-ketoglutarate dehydrogenases, but only when the organelle remains polarized and competent. Iron-dependent Fe-S cluster assembly is required for complexes I, II and III; its failure, whether from absolute deficiency or from oxidative damage, collapses electron flux at the same nodes. These pathways are not abstract; they are the concrete biochemical expression of the upstream ATP constraint that unifies cardiomyopathy, heart failure, arrhythmia, and atherosclerotic remodeling.

Integration with the EnSurf Framework and Interacting Systems

The three EnSurf pillars act on the cardiac circuit at multiple nodes and simultaneously improve the interacting pulmonary and gastrointestinal systems that determine cardiac outcomes.

Fuel prioritizes substrates mitochondria oxidize cleanly while limiting chronic fermentable load. Animal fats and proteins, microbially accessible carbohydrates, and intermittent ketosis restore the ancestral preference for fatty-acid oxidation, improve the NAD⁺/NADH ratio, and reduce lipotoxic intermediates. Ketone bodies supply an efficient alternative fuel precisely when fatty-acid pathways are impaired. Proper fuel reduces systemic insulin resistance (a shared driver of HFpEF, atherosclerosis, and right-heart strain), lowers inflammatory tone via the gut-heart axis, and improves iron-redox balance.

Circadian entrainment restores oscillatory gating of AMPK, sirtuins, and mTOR. Natural light-dark cycles and sleep integrity protect the nocturnal window of mitophagy and redox restoration that intermittent hypoxia and modern lighting destroy. Melatonin supports mitochondrial antioxidant capacity. Alignment reduces continuous substrate pressure on both cardiomyocytes and the gut barrier while stabilizing autonomic tone that influences arrhythmogenic threshold.

Strength hormesis expands mitochondrial density and quality systemically and, when applied through progressive resistance, improves left- and right-ventricular resilience, endothelial function, and systemic resolution competence. The ATP headroom required by continuous contractile and electrical work is raised; the same stimulus that protects skeletal muscle mitochondria protects the heart.

Layered mitochondrial supports can stabilize Complex I or IV function or redox balance where indicated, but they remain secondary. The substrate, light, and contractile stimuli already modulate the shared pathways across heart, lung, gut, and immune systems with lower cumulative risk. These interventions do not replace indicated pharmacologic therapy; they may address the upstream mismatch that makes those therapies necessary and reduce the probability that acute Crabtree-like compensations lock into Warburg architecture.

Conclusion

The heart is the distribution half of the dual-delivery architecture that powers oxidative phosphorylation. Atherosclerosis, cardiomyopathy, heart failure, arrhythmia, and right-heart strain are not independent entities. They are the chronic compensatory expressions of a myocardium and vasculature whose ATP-generating capacity, iron-redox balance, calcium-energetic coupling, and gut-heart dialogue have been eroded by mismatch. The same upstream constraint that produces pulmonary remodeling, gastrointestinal barrier failure, and systemic metabolic syndrome expresses itself in the heart as ischemic or hypertrophic remodeling, energy-starved contractility, and electrical instability.

On this hypothesis, the electrocardiogram and the electroretinogram are parallel reporters of the same bioenergetic reality: surface potentials that change when the mitochondrial engine can no longer sustain the ion gradients of high-demand, electrically active tissues. Interventions that restore ancestral fuel oxidation, circadian alignment, and strength hormesis increase the probability that acute compensations remain reversible and that chronic lock-in is attenuated across these domains. The engine, not the dashboard, remains the proper target. Cardiology, properly understood, is the clinical expression of the same metabolic philosophy that unifies the rest of the organism.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 23, 2026.

See the notice at the top of this page. Working hypothesis, not medical advice.